Clinical Trials Browser

Teratoma, Testicular, Teratoma, Ovarian, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Fallopian Tube Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Stomach Neoplasms, Teratoma, Testicular Neoplasms, Endometrial Neoplasms, Small Cell Lung Carcinoma

Clinical Trials

Superman

Patient Recall of Cancer Screening and Diagnosis

PROTOMEN

NeoPSMA

Effect of Ruxolitinib on Tumor Infiltrating Myeloid Cells

Randomized Phase II Study of ADT + Abiraterone vs ADT + Docetaxel + Abiraterone

PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer

A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence

Abbreviated Biparametric MRI (RSI + T2WI) for Prostate Cancer Detection: Correlation With Histopathology

REPRESENTATION

Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer

TALON

HRPCa-II

Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer

KATANA E3M

KATANA E6M

Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate Cancer

18F-PSMA PET/MRI for the Diagnosis of Clinically Significant Prostate Cancer

Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer

Single-Port Versus Multi-Port Robotic Radical Prostatectomy

Prostate MRI and Pylarify PSMA PET/CT

KOALA

A Study of Copanlisib in Combination with Degarelix in People with Prostate Cancer

Using Meditation for Oncology Anxiety

18F-rhPSMA-7.3 PET/MRI in Prostate Cancer Active Surveillance: a Pilot Study

Evaluating Race Specific AGE Accumulation As a Behavioral Biomarker Prostate Cancer Survivors

A Yoga Program for Patients Undergoing Prostate Cancer Surgery

LUNAAR

Prostatic Artery Embolization for the Treatment of Lower Urinary Tract Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy

TRACK

Neoadjuvant Listeria or Daratumumab in Prostate Cancer

Testing the Addition of Immunotherapy With Hu5F9-G4 (Magrolimab) to the Usual PARP Inhibitor, Olaparib for Treatment of Metastatic or Recurrent Breast or Castrate-Resistant Prostate Cancer With BRCA Mutations

PSMA-PET/MRI Low- and Intermediate-Risk Prostate Cancer

ARTGU

A Neoadjuvant Study of Abiraterone Acetate, Leuprolide Acetate, and Belzutifan in Men With Regional Prostate Cancer

Gallium-68 PSMA-11 PET in Participants With Prostate Cancer

HIIT PCa

A Novel Augmented Reality System (ARssist) for the Assistant Surgeon in Robotic Assisted Surgery

SMMART Adaptive Clinical Treatment (ACT) Trial

A Prospective Pilot Study for the Evaluation of 18F- Fluciclovine PET/MRI in Radio-recurrent Prostate Cancer (RRPC-PET/MRI Study)

URODETECT-WP2

A Study of Tazemetostat (Tazverik) Before Prostatectomy in Men With Prostate Cancer

CARE

Pioglitazone and Insulin Resistance in ADT

Atorvastatin Calcium in Preventing Metabolic Syndrome in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy

Neratinib in Patients With Metastatic Castration-Resistant Prostate Cancer

BioDFence® G3 For Full Nerve-Sparing Robotic-Assisted Radical Prostatectomy

Insulin Resistance and Androgen Deprivation Therapy

Evaluating Return to Continence and Potency Following Radical Prostatectomy

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors